# Predict Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia

> **NCT03670134** · NA · WITHDRAWN · sponsor: **Mayo Clinic**

## Conditions studied

- Barrett Esophagus

## Interventions

- **DEVICE:** The Nvision VLE Imaging System

## Key facts

- **NCT ID:** NCT03670134
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08-06
- **Primary completion:** 2022-10
- **Final completion:** 2022-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The company that supported the technology (volumetric laser endomicroscopy) is no longer operational due to the pandemic.
- **Last updated:** 2022-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03670134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03670134, "Predict Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03670134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*